Loading...
XHKG
2182
Market cap31mUSD
Jul 18, Last price  
0.40HKD
1D
0.00%
1Q
21.21%
IPO
-56.99%
Name

Tian Chang Group Holdings Ltd

Chart & Performance

D1W1MN
P/E
P/S
0.46
EPS
Div Yield, %
3.75%
Shrs. gr., 5y
Rev. gr., 5y
-15.48%
Revenues
540m
-22.64%
548,679,000401,178,000555,561,000572,864,000959,947,0001,251,074,000787,394,0001,117,688,0001,143,941,000697,514,000539,611,000
Net income
-14m
L
52,636,00017,761,00033,857,00020,078,00075,755,000127,196,00073,714,00096,264,000105,945,00023,457,000-13,665,000
CFO
0k
-100.00%
71,401,00056,203,00051,294,00091,823,000110,497,000232,509,00084,277,00094,275,000144,083,00096,264,0000
Dividend
Jun 12, 20240.015 HKD/sh

Profile

Tian Chang Group Holdings Ltd., an investment holding company, provides e-cigarette products and integrated plastic solutions in Hong Kong, the People's Republic of China, the United States, the United Kingdom, the Netherlands, Japan, India, Germany, and internationally. It operates through three segments: E-cigarettes Products, Integrated Plastic Solutions, and Medical Consumable Products. The Integrated Plastic Solutions segment designs, manufactures, and fabricates plastic injection moulds and plastic components, such as printer, copier, and air-conditioner parts; breathable office chair backs and accessories; engine covers and dash boards for automobile components; routers; camera and mobile power banks; and PET products. The E- cigarettes Products segment engages in the manufacture and sale of disposable and refillable e-cigarettes, battery rods, clearomisers, liquidpods, and heated tobacco devices as an original equipment manufacturer. The Medical Consumable Products segment manufactures and sells disposable face masks under the CAREWE brand, as well as personal protective equipment. Tian Chang Group Holdings Ltd. was founded in 2000 and is headquartered in Kwun Tong, Hong Kong.
IPO date
Mar 08, 2018
Employees
1,065
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
539,611
-22.64%
697,514
-39.03%
1,143,941
2.35%
Cost of revenue
569,611
710,475
1,053,334
Unusual Expense (Income)
NOPBT
(30,000)
(12,961)
90,607
NOPBT Margin
7.92%
Operating Taxes
2,875
2,464
10,881
Tax Rate
12.01%
NOPAT
(32,875)
(15,425)
79,726
Net income
(13,665)
-158.26%
23,457
-77.86%
105,945
10.06%
Dividends
(12,400)
(12,400)
Dividend yield
3.88%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
33,475
64,332
123,518
Long-term debt
16,693
5,243
9,008
Deferred revenue
10,021
Other long-term liabilities
14,795
10,784
(2,097)
Net debt
(79,821)
(95,641)
(34,627)
Cash flow
Cash from operating activities
96,264
144,083
CAPEX
(4,968)
(4,749)
Cash from investing activities
(3,253)
(2,215)
Cash from financing activities
(92,785)
(132,183)
FCF
19,664
55,012
186,094
Balance
Cash
129,989
132,590
135,520
Long term investments
32,626
31,633
Excess cash
103,008
130,340
109,956
Stockholders' equity
744,943
748,561
747,523
Invested Capital
698,599
725,819
815,700
ROIC
9.19%
ROCE
9.72%
EV
Common stock shares outstanding
620,000
626,184
623,459
Price
0.32
-38.24%
0.51
 
Market cap
195,300
-38.85%
319,354
 
EV
115,479
223,713
EBITDA
(30,000)
37,747
140,241
EV/EBITDA
5.93
Interest
5,436
7,208
Interest/NOPBT
7.96%